Bleeding disorders
Bleeding disorders
Updated: 09/16/2020
© Jun Wang, MD, PhD
Hemostasis
- Primary: Vasoconstriction, platelet activation
- Secondary: Coagulation cascades
- Results: Blood clot formation
Activation of platelets
Coagulation system
- Intrinsic pathway: XII, XI, IX, VIII (8-12 except 10)
- Extrinsic pathway: VII
- Common pathway: X, V, prothrombin (II),
fibrinogen (I) (4 smallest US dollar bills)
Etiology of bleeding disorders
- Vascular dysfunction, including vitamin C deficiency, telangiectasia, allergic purpura, purpura associated with infections such as meningococcus and Rocky Mountain spotted fever, etc
- Platelet disorders
Platelet dysfunctions associated with uremia, MDS,
medications (NSAIDs etc) Bernard-Soulier syndrome, etc
-
Coagulopathy
Other anticoagulants
- Excessive fibrinolysis, including antiplasmin deficiency
Clinical presentations
- Easy bleeding into skin, mucosa, body cavities
- Presentations associated with organ/tissue dysfunction caused by bleeding
- Chronic anemia
- Primary hemostasis disorders: Single site, immediate bleeding after challenge, petechiae
- Secondary hemostasis disorders: Multiple site, delayed bleeding after challenge, hematoma/hemarthrosis
Key laboratory approaches
- Platelet count and function tests
- Coagulation function tests
- PT and INR (extrinsic pathway)
- PTT (intrinsic pathway)
- Coagulation factor test
- Mild factor deficiencies will not cause prolonged PT or PTT
- Mixing studies: If PT or PTT are normalized by mixture with normal plasma, factor deficiency is suggested, if not, presence of inhibitor is suggested
General considerations
Practice questions I
Practice questions II
Back to contents
Comments
Post a Comment